These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 16498393

  • 1. Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference.
    Castro JE, Prada CE, Aguillon RA, Kitada S, Fukuda T, Motta M, Wu C, Dicker F, Sun G, Wang JY, Carson DA, Reed JC, Kipps TJ.
    Leukemia; 2006 Apr; 20(4):680-8. PubMed ID: 16498393
    [Abstract] [Full Text] [Related]

  • 2. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G.
    J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
    [Abstract] [Full Text] [Related]

  • 3. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
    Dicker F, Kater AP, Prada CE, Fukuda T, Castro JE, Sun G, Wang JY, Kipps TJ.
    Blood; 2006 Nov 15; 108(10):3450-7. PubMed ID: 16741250
    [Abstract] [Full Text] [Related]

  • 4. Drug-induced apoptosis in chronic lymphocytic leukemia.
    Stoetzer OJ, Pogrebniak A, Scholz M, Pelka-Fleischer R, Gullis E, Darsow M, Nüssler V, Wilmanns W.
    Leukemia; 1999 Nov 15; 13(11):1873-80. PubMed ID: 10557065
    [Abstract] [Full Text] [Related]

  • 5. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V, Gimmnich P, Hofmann HP, Grebe C, Römmele M, Leja A, Baudler M, Benimetskaya L, Gonser B, Pieles U, Maier T, Wagner T, Sanders K, Beck JF, Hanauer G, Stein CA.
    Oligonucleotides; 2006 Nov 15; 16(1):83-93. PubMed ID: 16584297
    [Abstract] [Full Text] [Related]

  • 6. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.
    J Leukoc Biol; 2005 Mar 15; 77(3):378-87. PubMed ID: 15582984
    [Abstract] [Full Text] [Related]

  • 7. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.
    Secchiero P, Melloni E, Tiribelli M, Gonelli A, Zauli G.
    J Leukoc Biol; 2008 Feb 15; 83(2):434-7. PubMed ID: 17998303
    [Abstract] [Full Text] [Related]

  • 8. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH, Mulkens CE, van Laar J, Derks IA, Suo G, Croon-de Boer F, van Oers MH, Eldering E, Wang JY, Kater AP.
    Leuk Lymphoma; 2015 Feb 15; 56(8):2439-47. PubMed ID: 25511680
    [Abstract] [Full Text] [Related]

  • 9. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, Chen W.
    Blood; 2010 Jun 17; 115(24):5041-52. PubMed ID: 20339095
    [Abstract] [Full Text] [Related]

  • 10. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 11. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH, Liu CC, Yen CC, Gau JP, Wang WS, Tzeng CH.
    Int J Cancer; 2009 Jul 01; 125(1):71-7. PubMed ID: 19291793
    [Abstract] [Full Text] [Related]

  • 12. CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis.
    Luo Y, Fu X, Ru R, Han B, Zhang F, Yuan L, Men H, Zhang S, Tian S, Dong B, Meng M.
    Arch Med Res; 2020 Apr 01; 51(3):233-244. PubMed ID: 32139108
    [Abstract] [Full Text] [Related]

  • 13. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
    Lenert P, Stunz L, YI AK, Krieg AM, Ashman RF.
    Antisense Nucleic Acid Drug Dev; 2001 Aug 01; 11(4):247-56. PubMed ID: 11572601
    [Abstract] [Full Text] [Related]

  • 14. Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells.
    Pepper C, Hooper K, Thomas A, Hoy T, Bentley P.
    Leuk Lymphoma; 2001 Jul 01; 42(3):491-8. PubMed ID: 11699414
    [Abstract] [Full Text] [Related]

  • 15. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
    Santidrián AF, Cosialls AM, Coll-Mulet L, Iglesias-Serret D, de Frias M, González-Gironès DM, Campàs C, Domingo A, Pons G, Gil J.
    Haematologica; 2007 Dec 01; 92(12):1631-8. PubMed ID: 18055986
    [Abstract] [Full Text] [Related]

  • 16. 4-arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patients.
    Billard C, Menasria F, Quiney C, Faussat AM, Finet JP, Combes S, Kolb JP.
    Exp Hematol; 2008 Dec 01; 36(12):1625-33. PubMed ID: 18922614
    [Abstract] [Full Text] [Related]

  • 17. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C.
    Leukemia; 2002 Mar 01; 16(3):327-34. PubMed ID: 11896535
    [Abstract] [Full Text] [Related]

  • 18. Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells.
    Wu CC, Castro JE, Motta M, Cottam HB, Kyburz D, Kipps TJ, Corr M, Carson DA.
    Hum Gene Ther; 2003 Jun 10; 14(9):849-60. PubMed ID: 12828856
    [Abstract] [Full Text] [Related]

  • 19. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA.
    Sester DP, Naik S, Beasley SJ, Hume DA, Stacey KJ.
    J Immunol; 2000 Oct 15; 165(8):4165-73. PubMed ID: 11035048
    [Abstract] [Full Text] [Related]

  • 20. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
    Nguyen TK, Rahmani M, Gao N, Kramer L, Corbin AS, Druker BJ, Dent P, Grant S.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2239-47. PubMed ID: 16609040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.